Please login to the form below

Not currently logged in
Email:
Password:

Business Research

This page shows the latest Business Research news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA and Mersana partner in potential $830m deal

Merck KGaA and Mersana partner in potential $830m deal

The companies will work together to develop novel antibody-drug conjugates. Merck KGaA and Mersana Therapeutics (Mersana) have entered into a research collaboration and commercial licence agreement aimed at discovering novel ... Paul Lyne, head of

Latest news

  • C-Suite keystones C-Suite keystones

    Similarly, my research shows that business success is usually attributable to many things. ... But are there exceptions? Might there be business equivalents of genes that are disproportionately significant?

  • COVID-19’s consequences COVID-19’s consequences

    Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School. ... In its business models, it was closer to its chemical industry roots than to today’s research-intensive,

  • Merck KGaA announces launch of start-up collaboration programme in Asia Merck KGaA announces launch of start-up collaboration programme in Asia

    The selected companies will receive up to 100, 000 in financial assistance, mentoring and coaching from Merck experts in areas of research, business development, strategy and finance. ... lead to ‘instrumental’ business cases or a partnership with

  • Sanofi launches Diversity, Equity & Inclusion Board Sanofi launches Diversity, Equity & Inclusion Board

    Dr Rohini Anand is a strategic business leader and author, with extensive expertise spanning executive leadership, human capital, global corporate responsibility, wellness and diversity equity and inclusion. ... general nedicines, Roy Papatheodorou,

  • Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment

    Speaking on the results of the trial, Dr Gregory Lubiniecki, vice president, Oncology Clinical Research at Merck Research Laboratories, commented: "While rates of endometrial carcinoma continue to rise globally, patients with ... advanced endometrial

More from news
Approximately 0 fully matching, plus 147 partially matching documents found.

Latest Intelligence

  • How the Royal Society’s EiR programme can help to drive UK innovation How the Royal Society’s EiR programme can help to drive UK innovation

    As an example, my own EiR programme at the University of Reading focuses on assessment of research commercialisation potential, business plan development of key projects and transformation planning to facilitate the ... Metrics need to be based on the

  • How early-stage clinical research is facilitating the new wave of personalised medicines How early-stage clinical research is facilitating the new wave of personalised medicines

    What is less well known is how early-stage clinical research has had to adapt to facilitate the new wave of gene therapy studies. ... Designing studies for gene therapies is not simply ‘business as usual’ for contract research organisations (CRO) and

  • The pursuit of patient diversity in clinical trials The pursuit of patient diversity in clinical trials

    Pharma is increasingly committed to ensuring trial populations are more diverse than they perhaps were in the past,” said Nuala Murphy, President, ICON Clinical Research Services. ... Patient-centricity was a conversation about good intentions rather

  • Back to the future Back to the future

    Six great shifts. My research first predicted that life sciences business models would adapt to the selection pressures created by shifts in our market’s sociological and technological environment. ... predictions then and, together, those six shifts

  • Patient journey mapping: exploring the clinical and the emotional journey Patient journey mapping: exploring the clinical and the emotional journey

    The adoption of one approach over another is entirely dependent on the needs of the stakeholders and the business requirements within the organisation. ... These data sets are used for the purposes of providing supporting information for business cases,

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

  • New faces at BioStrata, P\S\L Group and FCB Health New faces at BioStrata, P\S\L Group and FCB Health

    Carolyn Chamberlain (below) has joined P S L Group as Managing Director, Instar Europe, the group’s global market research business. ... Chamberlain will also partner with clients, exploring their business requirements and providing them with a suite

  • Marinomed appoints CFO, Robin Brown is named chair of Medicines Discovery Catapult and more Marinomed appoints CFO, Robin Brown is named chair of Medicines Discovery Catapult and more

    Most recently, Brown was the chief executive officer of KWS BioTest, a specialist immunology-based contract research organisation. ... Petti has held numerous roles in investment banking but began his career as a research scientists at OSI Pharmaceuticals

  • Kevin Sin joins GSK Kevin Sin joins GSK

    He becomes senior VP, head of worldwide business development. Kevin Sin has joined GlaxoSmithKline as its senior vice president, head of worldwide business development for pharmaceutical research and development. ... Kevin’s leadership skills,

  • Metrion Biosciences establishes scientific advisory board Metrion Biosciences establishes scientific advisory board

    Contract research organisation and drug discovery business Metrion Biosciences has established a scientific advisory board, which will provide strategic scientific guidance to the company. ... The new board will be chaired by Dr Keith McCullagh,

  • Pfizer’s Elizabeth Barrett joins Novartis as its oncology head Pfizer’s Elizabeth Barrett joins Novartis as its oncology head

    She has been instrumental in creating new commercial models, driving innovation in close partnership with research and development and leveraging business development opportunities. ... Her long-time commercial pharma industry experience, marketing

More from appointments
Approximately 0 fully matching, plus 37 partially matching documents found.

Latest from PMHub

  • Actionable Insights for Medical Affairs: Elusive or Within Reach?

    Collecting and disseminating data — and directing both internal and external traffic at the intersection of research, business, and education — is a pivotal, if sometimes exhausting, position that necessitates productive and effective

  • Article: From KOLs to KOIs – How to identify and engage the new healthcare influencers

    HCP perceptions . Desk research . Social media analysis . Introducing Influencer ID - KOI identification, profiling and mapping. ... Experience of KOI research at Research Partnership. As a business, we have started to see significant interest in KOI

  • Listening to heads AND hearts in healthcare Listening to heads AND hearts in healthcare

    What we don’t talk about as much is the business intelligence (BI) behind it. ... Our business intelligence and market research services close unintended gaps and help us stay focused on what matters; walking in the shoes of those we design solutions

  • Call for industry innovators to join working group

    From data to knowledge – enabling studies and research. For more information visit ibdregistry.org.uk/industry-forum-2021 or to register contact: admin@ibdregistry.org.uk. ... data to increase understanding of the care of people with IBD and their

  • YV Intelligence

    YV Intelligence is the top market research and business strategy consulting firm that offers in-depth market research reports and consulting services.

More from PMHub
Approximately 1 fully matching, plus 48 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...